ArticleMolecular oncology2020

The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe.

Stanislav Drápela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.